Literature DB >> 31838771

The Warburg effect and tumour immune microenvironment in extramammary Paget's disease: overexpression of lactate dehydrogenase A correlates with immune resistance.

K Urata1, I Kajihara1, H Miyauchi1, T Mijiddorj1, S Otsuka-Maeda1, R Sakamoto1, S Sawamura1, H Kanemaru1, S Kanazawa-Yamada1, K Makino1, J Aoi1, T Makino1, S Fukushima1, Y Komohara2, H Ihn1.   

Abstract

BACKGROUND: Extramammary Paget's disease (EMPD) is a rare malignant skin cancer. One of the hallmarks of cancers, including EMPD, is an enhancement of aerobic glycolysis, which is also known as the Warburg effect. In the last step of glycolysis, the enzyme lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactic acid, the accumulation of which contributes to the creation of an acidic tumour microenvironment. This in turn results in immunosuppression in various types of cancers. However, the contribution of these pathways has not been well-studied in EMPD.
OBJECTIVE: To investigate the significance of the Warburg effect and its contribution to the tumour immune microenvironment in EMPD.
METHODS: The mRNA expression levels of molecules involved in glycolysis and immune-related cytokines were examined by ddPCR. The number of immune cells was assessed by immunohistochemistry (IHC).
RESULTS: The levels of two glycolytic enzymes, HK2 and LDHA, in tumour tissues were significantly increased compared to those in paired-normal tissues. IHC analyses revealed increased numbers of PD-L1+ , PD-1+ , CD163+ M2 macrophages, Iba1+ macrophages and Foxp3+ Tregs that were associated with high LDHA levels in EMPD. ddPCR demonstrated that multiple cytokines including IL-4, IL-6, IL-10, TGF-β and CCL-2 were upregulated and associated with high LDHA levels in EMPD. Statistical analyses showed that IL-6 mRNA expression correlated with the number of CD163+ , Iba-1+ and Foxp3+ cells.
CONCLUSION: The Warburg effect contributes to immunomodulation in the tumour microenvironment and further elucidation may lead to better understanding of the pathogenesis of EMPD.
© 2019 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31838771     DOI: 10.1111/jdv.16145

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  WTAP mediates FOXP3 mRNA stability to promote SMARCE1 expression and augment glycolysis in colon adenocarcinoma.

Authors:  Yu Zhang; Xiaoxiao Tian; Yanli Bai; Xianmin Liu; Jingjing Zhu; Lamei Zhang; Jinliang Wang
Journal:  Mamm Genome       Date:  2022-09-29       Impact factor: 3.224

2.  Treatment of Metastatic Primary Extramammary Paget Disease With Combination Anlotinib and Tislelizumab: A Case Report and Review of the Literature.

Authors:  Xin Yin; Xiaoqing Li; Muli Li; Qing She; Yan Liu; Xiaodan Chen; Suhua Ma; Qian Ma; Zhangkan Huang; Lin Xu; Xiaozhun Huang; Zhengyin Zhan; Xu Che
Journal:  Front Med (Lausanne)       Date:  2022-05-24

3.  High Expression of Lactate Dehydrogenase A is a Potential Promoter of Malignant Behaviour in Extramammary Paget's Disease.

Authors:  Kohei Ogawa; Keiji Shimada; Toshihiro Takai; Yasuhiro Mitsui; Masamitsu Kuwahara; Hideo Asada
Journal:  Acta Derm Venereol       Date:  2021-01-25       Impact factor: 3.875

Review 4.  TGF-β links glycolysis and immunosuppression in glioblastoma.

Authors:  Lingli Gong; Li Ji; Daxing Xu; Jingjing Wang; Jian Zou
Journal:  Histol Histopathol       Date:  2021-07-29       Impact factor: 2.303

5.  Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma.

Authors:  Makito Miyake; Yuki Oda; Nobutaka Nishimura; Yosuke Morizawa; Sayuri Ohnishi; Kinta Hatakeyama; Tomomi Fujii; Shunta Hori; Daisuke Gotoh; Yasushi Nakai; Satoshi Anai; Kazumasa Torimoto; Shinji Tsukamoto; Hiromasa Fujii; Akira Kido; Kanya Honoki; Yoshiaki Matsumura; Eijiro Okajima; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

6.  Low levels of AMPK promote epithelial-mesenchymal transition in lung cancer primarily through HDAC4- and HDAC5-mediated metabolic reprogramming.

Authors:  Shoujie Feng; Li Zhang; Xiucheng Liu; Guangbin Li; Biao Zhang; Ziwen Wang; Hao Zhang; Haitao Ma
Journal:  J Cell Mol Med       Date:  2020-06-09       Impact factor: 5.310

7.  Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.

Authors:  Brendan John Guercio; Gopa Iyer; Wajih Zaheer Kidwai; Mario E Lacouture; Soleen Ghafoor; Anthony M Rossi; David N Assis; Ying-Bei Chen; Klaus J Busam; Yelena Y Janjigian; Komal Jhaveri; Darren R Feldman; Anne Capozzi; Vanessa Figueroa; Dean F Bajorin; Jonathan E Rosenberg; Travis J Hollmann; Samuel A Funt
Journal:  Case Rep Oncol       Date:  2021-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.